2nd Annual Cell Culture Engineering World
26-27 June,2013 | Singapore
In 2013, it will bring together cell culture industry leaders from both research and industrial manufacturing field to share and debate on latest cell culture technologies and best practices for optimized and enhanced biomanufacturing.
Key speakers and advisors include:
· Dou Chang Lin, Chief Technology Officer, Biologic R&D, Luye Pharma Group
· Gary Khoo, Senior Technical Services Manager, Baxter Bioscience, Singapore
· Dr. Peter Grey, Director, Australian Institute for Bioengineering and Nanotechnology
· Dr. Donald Gerson, Chief Executive Ocer, Pnuvax, Canada
· Dr. Xinhua (Joe) Zhou, Chief Executive Ocer, Genor BioPharma Co.,Ltd
· Mr. Tim Hughes, Senior Director, Biotech Manufacturing, CSL Behring, Australia
· Mr. Daniel Hagewiesche, Manufacturing Director Genentech
Key topics for 2013 include:
· Cell line development and optimization
· Cell line selection and technology transfer best practices
· CHO cells vs. other cell lines for biosimilars production
· Approaches to speed up cell culture media development
· Cell culture process design and media formulation and development
· QbD and PAT in cell culture
· Single-use bioreactors for cell culture manufacturing
· Best practices for cell culture scale-up from pilot to commercial
· Stem cell culture media selection and optimization

Why Cell Culture Engineering World 2013?
Cell culture is of vital importance in the life sciences industry for both research and industrial use. On the research front, cell cultures find extensive application in toxicology studies for initial-stage screening of compounds in drug discovery. On the industrial front, the rising vaccine, biologics and emerging cell and tissue therapies production are expected to drive demand for cultures specific to its cell lines.
Global market for cell and tissue culture supplies is projected to surpass US $6 billion by 2015, as stated in a recent report published by Global Industry Analysts, Inc. The US represents the largest market for cell/tissue culture supplies in the world, while Asia's contribution is projected to reach US$720 million by 2015, driven by the rising popularity of biopharmaceuticals, advances in biotechnology and life science research coupled with broader range of application areas.
Cell and tissue culture involves a diverse assortment of media, sera and reagents. Finding the right cell line, the right mix of media for the specific cells/tissues is of vital importance to the success of the culture and biomanufacture. While Asia is emerging to be an important player in the production of vaccine, protein therapeutics and cell therapeutics, it’s essential than ever to understand how to choose the right cell lines, the right media mix, the right bioreactor and the right methodology.
Cell Culture Engineering World Asia serves as the platform for cell culture community in Asia to exchange new ideas, discuss best practices and share latest technologies. It will also be cell culture solution providers' one stop solution to get your company's voice heard in order to shape and grow your future market share in this surging industry!
Sponsor and Exhibit
Be part of the ONLY and most focused cell culture industry gathering of the year!
Too many conferences but very few really understand your business? Too many biomanufacturing conferences but you rarely meet the right job title, the right level decision makers, and at the right timing? IMAPAC understands that and strive to bring together a much targeted pool of people that is really interested in what you are going to say! Look no further!
Cell Culture Engineering World Asia 2013 will give you the unique opportunity to position your business in front of decision makers from Asia’s most innovative and progressive companies involved in cell culture in Asia. In order to get the right audience for you, our internal resources are fully geared towards attracting the largest and most active companies in the bioprocess industry in Asia. We also work with a wide range of media partners and industry bodies to guarantee this audience.
· Educate the market about what you offer.
· Position yourselves as leaders in your field alongside key industry figures.
· Raise brand awareness
· Enjoy the option of privately arranged meetings and consultations with selected potential clients.
· Hold face to face meetings with your target profile
Who should sponsor?
· Contract Manufacturing Organisations
· Equipment Providers
· Cell Culture media and consumable suppliers
· Cell lines and Technology platforms
· Law Firms
· Consultants
Attendee profile
Job Title
· Head of Cell Culture (50%)
· Scientists/Engineers (25%)
· Tech Transfer (10%)
· Business Development (10%)
· CEO/CSO (5%)
|
Industry Profile
· Academics (10%)
· Vaccine Manufactures (20%)
· Protein Therapeutics Manufactures (30%)
· Stems Cells Companies (15%)
· CMO (8%)
· Cell line (5%)
· Technology Provider (12%) |
Country
· Singapore (30%)
· Japan (15%)
· Korea (10%)
· China (15%)
· India (5%)
· Australia (5%)
· USA (10%)
· Europe (10%)
|
Pricing
PACKAGES & OFFER DEADLINES |
Limited Super
1st March |
Limited Special
14th May |
Early
Bird
14th June |
Standard Price
|
2 Day (Conference) Pass: 26 - 27 June 2013 |
SGD 2,195 |
SGD 2,395 |
SGD 2,595 |
SGD 2,795 |
Continue with booking if you have read and understood the terms and conditions given below |
|
Natasha Jiandani
Marketing Manager
IMAPAC PTE LTD
298 Tiong Bahru Road #20-04 Central Plaza Singapore 168730